Research Points to New Therapies to Lessen the Severity of Delusions for Patients with Schizophrenia
en-GBde-DEes-ESfr-FR

Research Points to New Therapies to Lessen the Severity of Delusions for Patients with Schizophrenia

18/08/2026 Elsevier

Findings in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging suggest that volatility priors are modifiable, and the brain’s predictive settings stabilize as delusions subside

August 18, 2026 New research has found that improvements to the severity of delusions in patients with schizophrenia-spectrum disorder recovering from an acute psychotic episode were significantly associated with reductions in volatility priors—someone’s expectations about the unpredictability of their environment. The findings from the new study, appearing in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, published by Elsevier, suggest that volatility priors are modifiable, pointing to a potential novel treatment target.

As the most common psychotic symptom, delusions are strongly held beliefs that persist despite contradictory evidence and can cause significant distress and disability for millions of people around the world. Defined by the DSM-5 as “beliefs based on false inference,” there is limited knowledge about how these false inferences arise. Previous research suggests that delusional thinking may be related to how people experience volatility priors in their environment.

In schizophrenia-spectrum disorders, the brain’s volatility prior is often set abnormally high, so patients expect the world to be unpredictable, chaotic, and unstable even when it is not. To make sense of this, the brain generates delusions, which can be devastating to patients and families and contribute to social isolation, suicidality, incarceration, and functional disability. Current clinical approaches offer variable and often poor treatment options.

“Patients deserve more effective treatments,” explains lead investigator Julia M. Sheffield, PhD, Vanderbilt University Medical Center, Department of Psychiatry and Behavioral Sciences. “We sought to extend previous cross-sectional research and ask whether these volatility priors change alongside delusion severity, suggesting a state-marker (temporary condition) that could be modified with treatment, or whether they are stably elevated in patients prone to delusions, suggesting a trait-marker (permanent vulnerability) that could be a target for prevention.

Seventy-five adults with schizophrenia-spectrum disorders recovering from an acute psychotic episode that included delusional thought content were recruited from an inpatient psychiatric hospital. Researchers assessed volatility priors and delusional thinking at six timepoints over six months. Data were compared with a non-clinical control group of 71 individuals. To estimate volatility priors, participants performed a probabilistic reversal learning task, which was analyzed using computational modeling.

At the beginning of the study participants with schizophrenia-spectrum disorders had significantly elevated volatility priors compared to the control group. The severity of delusional thinking, paranoia, and volatility priors remained elevated at the end of six-month study period in schizophrenia-spectrum disorder, never fully normalizing. Critically, volatility priors were longitudinally associated with delusional thinking and paranoia, but not with depression or worry. Results remained unchanged after controlling for antipsychotic medication and baseline cognitive ability. There is also some evidence of stronger associations with delusions of a paranoid/persecutory theme, consistent with previous work.

Longitudinal assessment of a cognitive process using a behavioral paradigm can be challenging due to practice effects. People can learn the task and improve in their behavior as a result of task exposure, rather than a fundamental change in their cognitive state. Although investigators worked to mitigate it, their findings are confounded by this effect. However, despite that, patients continued to show elevated volatility priors at six months, at their sixth exposure to the task. This provided some validation that the task was not simply being over-learned, but that the task and modeling scheme were sensitive to volatility priors above and beyond practice effects.

“Leveraging the unique opportunity to recruit schizophrenia-spectrum disorder participants with delusions during an acute psychiatric episode and follow them over time, we demonstrate that a computational marker of belief updating – volatility priors – are significantly elevated at baseline, reduce over time, and longitudinally relate to the severity of specific, well-characterized clinical delusions,” notes Dr. Sheffield. “These data suggest that volatility priors are a state-sensitive cognitive marker of delusional thinking that can change with recovery, making it a potential candidate for treatment development to improve clinical delusions.”

Historically, delusions have been treated broadly with antipsychotic medications that dampen dopamine systems. By identifying that volatility priors are elevated at baseline and reduce over time in relation to reductions in delusion severity, this study provides foundational evidence that adjusting someone’s expectations about the volatility or unpredictability of their environment is a potential new treatment target.

Dr. Sheffield concludes, “These findings are an exciting step in understanding the mechanisms of delusions and lay the groundwork for bridging computational psychiatry and clinical treatment. Psychological interventions, such as cognitive behavioral therapy for psychosis, can incorporate this knowledge to develop novel treatments, promoting recovery from a disabling and distressing symptom of serious mental illness. The ultimate task is to improve the lives of patients and families.”

Editor-in-Chief of Biological Psychiatry: Cognitive Neuroscience and Neuroimaging Cameron S. Carter, MD, University of California Irvine School of Medicine, adds, “This research represents the first time that volatility priors have been assessed longitudinally in psychotic disorders during recovery. By tracking these changes over six months, the investigators provide the most comprehensive picture yet of how this underlying brain mechanism drives the severity of delusions.”

"Longitudinal Associations Between Volatility Priors and Delusions in Individuals Recovering from an Acute Psychotic Episode," by Julia M. Sheffield, Lauren M. Hall, Jinyuan Liu, Essence Leslie, Ali F. Sloan, Kendall Beals, Annalise Halverson, Sarah G. Vassall, Praveen Suthaharan, Neil D. Woodward, Stephan Heckers, and Philip R. Corlett (https://doi.org/10.1016/j.bpsc.2026.06.013). It appears online in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, published by Elsevier. The article is openly available at https://www.biologicalpsychiatrycnni.org/article/S2451-9022(26)00188-6/fulltext.
18/08/2026 Elsevier
Regions: Europe, Netherlands
Keywords: Health, Medical, Well being, Society, Psychology

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Testimonials

For well over a decade, in my capacity as a researcher, broadcaster, and producer, I have relied heavily on Alphagalileo.
All of my work trips have been planned around stories that I've found on this site.
The under embargo section allows us to plan ahead and the news releases enable us to find key experts.
Going through the tailored daily updates is the best way to start the day. It's such a critical service for me and many of my colleagues.
Koula Bouloukos, Senior manager, Editorial & Production Underknown
We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet

We Work Closely With...


  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2026 by AlphaGalileo Terms Of Use Privacy Statement